FI891308A0 - NYA POLYPEPTIDER MED TILLVAEXTFAKTORAKTIVITET OCH DESSA KODANDE NUCLEIN SYRASE SEQUENTOR. - Google Patents

NYA POLYPEPTIDER MED TILLVAEXTFAKTORAKTIVITET OCH DESSA KODANDE NUCLEIN SYRASE SEQUENTOR.

Info

Publication number
FI891308A0
FI891308A0 FI891308A FI891308A FI891308A0 FI 891308 A0 FI891308 A0 FI 891308A0 FI 891308 A FI891308 A FI 891308A FI 891308 A FI891308 A FI 891308A FI 891308 A0 FI891308 A0 FI 891308A0
Authority
FI
Finland
Prior art keywords
tillvaextfaktoraktivitet
syrase
sequentor
kodande
polypeptider
Prior art date
Application number
FI891308A
Other languages
Finnish (fi)
Other versions
FI891308A (en
Inventor
Joseph P Brown
Hans Marquardt
Gregory A Bruce
Anthony F Purchio
Daniel R Twardzik
George J Todaro
Timothy M Rose
Shiu-Lok Hu
Wen Chang
Suo Win Liu
Thomas J Franceschini
Mohammed Shoyab
Greg Plowman
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of FI891308A0 publication Critical patent/FI891308A0/en
Publication of FI891308A publication Critical patent/FI891308A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF] (urogastrone)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FI891308A 1988-03-24 1989-03-20 NYA POLYPEPTIDER MED TILLVAEXTFAKTORAKTIVITET OCH DESSA KODANDE NUCLEIN SYRASE SEQUENTOR. FI891308A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17265388A 1988-03-24 1988-03-24

Publications (2)

Publication Number Publication Date
FI891308A0 true FI891308A0 (en) 1989-03-20
FI891308A FI891308A (en) 1989-09-25

Family

ID=22628611

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891308A FI891308A (en) 1988-03-24 1989-03-20 NYA POLYPEPTIDER MED TILLVAEXTFAKTORAKTIVITET OCH DESSA KODANDE NUCLEIN SYRASE SEQUENTOR.

Country Status (22)

Country Link
JP (1) JPH0279981A (en)
KR (1) KR890014743A (en)
AU (2) AU3169589A (en)
BE (1) BE1004202A5 (en)
CH (1) CH681081A5 (en)
DE (1) DE3910084A1 (en)
DK (1) DK146789A (en)
ES (1) ES2013408A6 (en)
FI (1) FI891308A (en)
FR (1) FR2632321A1 (en)
GB (1) GB2219799B (en)
GR (1) GR1000876B (en)
HU (1) HUT50501A (en)
IE (1) IE890950L (en)
IL (1) IL89673A0 (en)
IT (1) IT1234961B (en)
LU (1) LU87489A1 (en)
NL (1) NL8900724A (en)
NO (1) NO891273D0 (en)
NZ (1) NZ228427A (en)
PT (1) PT90118B (en)
SE (1) SE8901031L (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
EP0444961A1 (en) * 1990-03-02 1991-09-04 Bristol-Myers Squibb Company Her3: A novel EGF receptor homolog
EP0739984A1 (en) * 1995-04-26 1996-10-30 San Tumorforschungs-Gmbh Bivalent polypeptides containing at least two domains
AU5549296A (en) * 1996-04-10 1997-10-29 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein
US6852506B1 (en) 1996-04-10 2005-02-08 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983004030A1 (en) * 1982-05-06 1983-11-24 Applied Molecular Genetics, Inc. The manufacture and expression of genes for urogastrone and polypeptide analogs thereof
JPS6028994A (en) * 1983-07-08 1985-02-14 Wakunaga Seiyaku Kk (21-leucine) human urogastrone, corresponding gene, corresponding recombinant plasmid, transformed cell and their preparation
WO1985002198A1 (en) * 1983-11-01 1985-05-23 Amgen Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides
JP2554459B2 (en) * 1984-07-02 1996-11-13 アース製薬 株式会社 β-urogastron gene, corresponding plasmid recombinant and corresponding transformant
EP0199769A4 (en) * 1984-10-30 1989-11-29 Oncogen Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides.
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
GB2210618B (en) * 1987-10-08 1991-10-16 British Bio Technology Synthetic egf gene
ES2081801T3 (en) * 1987-10-30 1996-03-16 Bristol Myers Squibb Co EXPRESSION PLASMIDS.
EP0372005A4 (en) * 1987-10-30 1990-06-26 Oncogen Expression systems for preparation of polypeptides in prokaryotic cells.

Also Published As

Publication number Publication date
NL8900724A (en) 1989-10-16
LU87489A1 (en) 1989-10-26
SE8901031L (en) 1989-09-25
PT90118B (en) 1994-07-29
FI891308A (en) 1989-09-25
AU2990492A (en) 1993-03-04
BE1004202A5 (en) 1992-10-13
NO891273D0 (en) 1989-03-22
ES2013408A6 (en) 1990-05-01
DK146789D0 (en) 1989-03-22
GB8906758D0 (en) 1989-05-10
GR1000876B (en) 1993-03-16
CH681081A5 (en) 1993-01-15
KR890014743A (en) 1989-10-25
NZ228427A (en) 1993-03-26
IL89673A0 (en) 1989-09-28
DE3910084A1 (en) 1989-11-16
AU3169589A (en) 1989-09-28
SE8901031D0 (en) 1989-03-22
PT90118A (en) 1989-11-10
GB2219799A (en) 1989-12-20
GR890100185A (en) 1990-01-19
JPH0279981A (en) 1990-03-20
IT8919917A0 (en) 1989-03-24
DK146789A (en) 1989-09-25
IE890950L (en) 1989-09-24
IT1234961B (en) 1992-06-09
GB2219799B (en) 1992-10-14
HUT50501A (en) 1990-02-28
FR2632321A1 (en) 1989-12-08

Similar Documents

Publication Publication Date Title
FI906468A0 (en) NYA VISKOSITETSINDEXFOERHOEJANDE KOMPOSITIONER OCH NEWTONSK SMOERJMEDELSBLANDNING.
FI905109A0 (en) NYA HYALURONSYRASAMMANSAETTNINGAR INNEHAOLLANDE KOMPOSITIONER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI895860A0 (en) NYA BENZOESYRA- OCH PHENYLETTEXYRADERIVAT.
FI871788A0 (en) NYA KINOLINDERIVAT OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.
FI891167A (en) NYA YMPADE SULFONERADE POLYESTRAR FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH DERAS ANVAENDNING FOER KLISTRING AV TEXTILTRAODAR OCH -FIBER.
FI892423A (en) NYA POLYANHYDRIDER.
FI893945A (en) SKAERNINGS- OCH OEPPNINGSFOERFARANDE OCH ANORDNING FOER REKTANGULAERA FOERPACKNINGAR OEVERDRAGNA MED FOERPACKNINGSMATERIAL.
FI875698A0 (en) NYA KOAGULERINGS- OCH FILTRERINGSHJAELPMEDEL OCH DERAS ANVAENDNING.
FI894601A0 (en) NYA POLYISOCYANATSAMMANSAETTNINGAR.
FI892506A (en) NYA MELLANPRODUKTER OCH FOERFARANDE FOER FRAMSTAELLNING AV ORGANISKA SYROR.
FI890745A0 (en) KYLTORN MED LAOG SILHUETT OCH MED FYLLSTRUT MED TRAPETSFORM.
FI892993A0 (en) NYA AMIDINO- OCH GUANIDINOFOERENINGAR.
FI893451A0 (en) NYA PROTEINER.
FI895871A0 (en) NYA BENZOPYRANYLPYRROLINONDERIVAT.
FI891308A0 (en) NYA POLYPEPTIDER MED TILLVAEXTFAKTORAKTIVITET OCH DESSA KODANDE NUCLEIN SYRASE SEQUENTOR.
FI884890A0 (en) NYA ISOPOLYPEPTIDER OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.
FI890846A (en) NYA TIORODAMINER OCH NYTT FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI893118A0 (en) NYA FOERENINGAR.
FI911403A0 (en) NYA KINOLINDERIVAT OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI895988A0 (en) OLIGOMERA POLYESTRAR OCH POLYAMIDER MED DIPIPERIDYLTRIAZINGRUPPER.
FI891640A (en) NYA FOERENINGAR.
FI890695A (en) NYA ASPARTATTRANSKARBAMYLAS -INHIBITORER.
FI892862A (en) FOERBRAENNINGSMOTORMASKIN MED FLERA CYLINDRAR OCH AVGASLEDNING.
FI893708A (en) NYA CYKLODEXTRINGLYKOSYLTRANSFERASER.
FI906470A0 (en) OXIDATIONSHAORFAERGNINGSMEDEL MED NYA KOPPLINGSFAERGER.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ONCOGEN